miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3β/NF-κB signaling
Acta Biochimica et Biophysica Sinica · 2025
DOI: 10.3724/abbs.2025038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Guangzhi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, MicroRNAs, Liver Neoplasms, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a highly fatal form of malignancy that seriously threatens patient survival. The global 5-year survival rate for HCC patients ranges from 15% to 19%, and nearly 80% of patients are diagnosed at an advanced stage. Therefore, exploring the mechanism of HCC development and identifying biomarkers and therapeutic targets for HCC are vital. MicroRNAs (miRNAs), a class of noncoding single-stranded RNAs, are 20-24 nucleotides (nt) long. They play pivotal roles in modulating the progression of diverse diseases. The specific role of miR-32-5p in the development of HCC remains unclear. In this study, qRT-PCR is utilized to precisely determine the downregulated expression levels of miR-32-5p in HCC. Subsequently, functional analysis reveals the suppressive role of miR-32-5p in modulating the proliferative and migratory capabilities of HCC cells. Glycogen synthase kinase 3β (GSK3β) has emerged as a potential target of miR-32-5p, which is confirmed through a dual-luciferase reporter assay. Notably, the expression of GSK3β in HCC tissue specimens is negatively correlated with the abundance of miR-32-5p, and patients with high GSK3β expression have shorter survival time. Furthermore, the targeted downregulation of GSK3β remarkably impedes the proliferation and migration of tumor cells. This study suggests that miR-32-5p inhibits the proliferation and migration of HCC through regulating the GSK3β/NF-κB signaling pathway. Therefore, this study reveals that miR-32-5p exerts its suppressive effect on HCC progression, suggesting that it is a promising target for both diagnostic and targeted therapeutic interventions against HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, China.
- School of Medical Imaging, Shandong Second Medical University, Weifang 261053, China.
- Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
- Department of Intervention Radiology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Zitieren
APA
Wang, G., Yang, Q., Han, Y., Zhang, Y., Pan, W., Ma, Z., Tian, H., & Qu, X. (2025). miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3β/NF-κB signaling. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025038
Vancouver
Wang G, Yang Q, Han Y, Zhang Y, Pan W, Ma Z, et al. miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3β/NF-κB signaling. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025038
BibTeX
@article{Wang2025,
author = {Wang, Guangzhi and Yang, Qianqian and Han, Yaqi and Zhang, Yunlong and Pan, Wei and Ma, Zhongliang and Tian, Hui and Qu, Xudong},
title = {miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3β/NF-κB signaling},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2025038}
}
EUVIMED